• Drug: Ibsrela (tenapanor)
  • Manufacturer: Ardelyx

  • Route of Administration: Oral

  • Site of Care: Outpatient

  • Approved Indication: treatment of irritable bowel syndrome with constipation in adults

  • Disease: irritable bowel syndrome with constipation (IBS-C)
  • Therapeutic Area: Gastroenterology
  • Enrollment Form Link: ibsrela-hcp.com/prescribing
  • Phone Number: 844-427-7352
  • Fax Number: 877-765-7664
  • Product Website: ibsrela.com